Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04638621 · ClinicalTrials.gov registry record
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study
A clinical trial of Dilated Cardiomyopathy, sponsored by Ohio State University.
- Recruiting
- Registry status
- 650
- Enrollment target
- 1
- Study location
NCT04638621: Recruiting study of Dilated Cardiomyopathy, sponsored by Ohio State University.
NCT04638621 is a study of Dilated Cardiomyopathy that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 650 participants, above the 155-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (319% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04638621, a study of Dilated Cardiomyopathy, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Study is an ancillary study from the parent study, DCM Precision Medicine Study. The rationale for the DCM-CMR study is to leverage cardiac magnetic resonance (CMR) imaging to detect earliest findings of DCM in the at-risk family members enrolled into the parent study.
Primary Outcome
The burden of likely pathogenic or pathogenic variants in DCM genes in first-degree relatives and the association with worse values of CMR measures of myocardial tissue characterization will be analyzed, after controlling for biologically relevant covariates.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-04 |
What NCT04638621 shows while recruiting
NCT04638621 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, above the 155-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (319% higher).
The record links to 1 condition, with Dilated Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT04638621 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04638621 about?
NCT04638621 is a clinical study titled "Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study". The Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Study is an ancillary study from the parent study, DCM Precision Medicine Study. The rationale for the DCM-CMR study is to leverage cardiac magnetic resonance (CMR) imaging to detect earliest findings of DCM in the at-risk family member...
What is the current status of trial NCT04638621?
This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2021-04-01. Estimated completion is 2026-04.
What conditions does trial NCT04638621 study?
This clinical trial studies the following conditions: Dilated Cardiomyopathy.
Who is sponsoring clinical trial NCT04638621?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04638621 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dilated Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
RECRUITING · Phase 1
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
RECRUITING · NA
-
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
RECRUITING · NA
-
Pediatric Cardiomyopathy Mutation Analysis
RECRUITING
-
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
COMPLETED · Phase 2
-
Nesiritide - Dilated Cardiomyopathy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI